Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Barber

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
British Journal of Diseases of the Chest|January 1, 1984
Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancerN Thatcher, D Honeybourne, J Wagstaff, et al.
Journal of Nursing Care Quality|July 24, 2025
Developing a Medication Administration Observation Checklist: Key Insights for Standardized Reporting MethodologyMadison Hickey, Brittany V Barber, Chloe Flynn, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 29, 2003
Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinicSarah J Lewis, Nicola M Cherry, Robert McL Niven, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 6, 2014
Nodal staging in lung cancer: a risk stratification model for lymph nodes classified as negative by EBUS-TBNAMatthew Evison, Julie Morris, Julie Martin, et al.
Journal of Bronchology & Interventional Pulmonology|April 19, 2015
Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective studyMatthew Evison, Philip A J Crosbie, Raffaele Califano, et al.
Cancer|November 15, 1987
Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancerN Thatcher, T Cerny, R Stout, et al.
Mutation Research|January 24, 2012
Elevated N3-methylpurine-DNA glycosylase DNA repair activity is associated with lung cancerPhilip A J Crosbie, Amanda J Watson, Raymond Agius, et al.
Lancet (London, England)|May 8, 1982
11-week course of sequential methotrexate, thoracic irradiation, and moderate-dose cyclophosphamide for "limited"-stage small-cell bronchogenic carcinoma. A study from the Manchester Lung Tumour GroupN Thatcher, P V Barber, R D Hunter, et al.
Placenta|April 7, 2023
Activin A and pathologies of pregnancy: a reviewCourtney V Barber, Jennifer H Yo, Rahana Abdul Rahman, et al.
Cancer|September 15, 1985
Three months' treatment with cyclophosphamide, VP-16-213 followed by methotrexate and thoracic radiotherapy for small cell lung cancerN Thatcher, R D James, W P Steward, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
British Journal of Diseases of the Chest|January 1, 1984
Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancerN Thatcher, D Honeybourne, J Wagstaff, et al.
Journal of Nursing Care Quality|July 24, 2025
Developing a Medication Administration Observation Checklist: Key Insights for Standardized Reporting MethodologyMadison Hickey, Brittany V Barber, Chloe Flynn, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 29, 2003
Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinicSarah J Lewis, Nicola M Cherry, Robert McL Niven, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 6, 2014
Nodal staging in lung cancer: a risk stratification model for lymph nodes classified as negative by EBUS-TBNAMatthew Evison, Julie Morris, Julie Martin, et al.
Journal of Bronchology & Interventional Pulmonology|April 19, 2015
Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective studyMatthew Evison, Philip A J Crosbie, Raffaele Califano, et al.
Cancer|November 15, 1987
Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancerN Thatcher, T Cerny, R Stout, et al.
Mutation Research|January 24, 2012
Elevated N3-methylpurine-DNA glycosylase DNA repair activity is associated with lung cancerPhilip A J Crosbie, Amanda J Watson, Raymond Agius, et al.
Lancet (London, England)|May 8, 1982
11-week course of sequential methotrexate, thoracic irradiation, and moderate-dose cyclophosphamide for "limited"-stage small-cell bronchogenic carcinoma. A study from the Manchester Lung Tumour GroupN Thatcher, P V Barber, R D Hunter, et al.
Placenta|April 7, 2023
Activin A and pathologies of pregnancy: a reviewCourtney V Barber, Jennifer H Yo, Rahana Abdul Rahman, et al.
Cancer|September 15, 1985
Three months' treatment with cyclophosphamide, VP-16-213 followed by methotrexate and thoracic radiotherapy for small cell lung cancerN Thatcher, R D James, W P Steward, et al.
Pageof 7